Journey Medical Corp
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $61.9M | $56.1M | $79.2M | $73.7M | $63.1M |
| Cost of revenue | $20.9M | $20.9M | $22.9M | $30.8M | $32.1M |
| Selling, general & administrative | $44.4M | $40.2M | $43.9M | $59.5M | $39.8M |
| Research and development | $480,000 | $9.9M | $7.5M | $10.9M | $2.7M |
| Operating income | -$8.2M | -$13.7M | -$2.1M | -$27.5M | -$34.9M |
| Interest expense | $3.7M | $2.7M | $1.7M | $2.0M | $7.0M |
| Pretax income | -$11.4M | -$14.6M | -$3.6M | -$29.6M | -$42.4M |
| Income tax expense | $60,000 | $61,000 | $221,000 | $63,000 | $1.6M |
| Net income | -$11.4M | -$14.7M | -$3.9M | -$29.6M | -$44.0M |
| Balance Sheet | |||||
| Cash and equivalents | $24.1M | $20.3M | $27.4M | $32.0M | $49.1M |
| Current assets | $66.9M | $48.2M | $56.5M | $77.7M | $84.5M |
| Total assets | $94.6M | $80.2M | $76.8M | $105.2M | $97.3M |
| Current liabilities | $37.4M | $35.2M | $41.9M | $66.8M | $51.6M |
| Total liabilities | $62.7M | $60.2M | $56.5M | $88.2M | $55.2M |
| Total debt | $26.2M | $26.2M | $15.8M | $27.9M | — |
| Stockholders' equity | $31.9M | $20.1M | $20.4M | $17.0M | $42.0M |
| Cash Flow Statement | |||||
| Cash from operations | -$12.4M | -$9.1M | $5.2M | -$13.5M | -$2.2M |
| Depreciation and amortization | — | — | — | — | $0 |
| Stock-based compensation | $6.3M | $6.1M | $2.6M | $4.4M | $2.5M |
| Capital expenditure | — | $15.0M | $5.0M | $20.0M | $0 |
| Free cash flow | — | -$24.1M | $240,000 | -$33.5M | -$2.2M |
Shares outstanding 27.5M · Free float 26.6%
Annual filing data through FY ended December 31, 2025; float as of July 16, 2026.